Overexpression of CUEDC2 Predicts Poor Prognosis in Ovarian Serous Carcinomas

Wang, Aichun; Guo, Chao; Sun, Yunfei; Lu, Lijuan; Wang, Yun; Wang, Qiong; Zhang, Yan; Zhang, Hui; Wang, Li; Gu, Yiqun; Liu, Aijun

doi:10.7150/jca.11420



International Journal of Biological Sciences

International Journal of Medical Sciences

Theranostics

Journal of Genomics

Nanotheranostics

Global reach, higher impact

Full Text | PDF

J Cancer 2015; 6(6):542-547. doi:10.7150/jca.11420 This issue Cite

Research Paper

Overexpression of CUEDC2 Predicts Poor Prognosis in Ovarian Serous Carcinomas

Aichun Wang^{1, 2, #}, Chao Guo^{1, #}, Yunfei Sun², Lijuan Lu², Yun Wang¹, Qiong Wang¹, Yan Zhang³, Hui Zhang², Li Wang², Yiqun Gu², Aijun Liu^1,✉

1. Department of Pathology, People's Liberation Army General Hospital, Beijing, 100853, China
2. Department of Pathology, Haidian Maternal & Children Health Hospital, Beijing, 100080, China
3. Department of Obsteristics and Gynecology, People's Liberation Army General Hospital, Beijing, 100853, China
# These authors contributed equally to this project.

Citation:

Wang A, Guo C, Sun Y, Lu L, Wang Y, Wang Q, Zhang Y, Zhang H, Wang L, Gu Y, Liu A. Overexpression of CUEDC2 Predicts Poor Prognosis in Ovarian Serous Carcinomas. J Cancer 2015; 6(6):542-547. doi:10.7150/jca.11420. https://www.jcancer.org/v06p0542.htm

Other styles

Abstract

CUEDC2, a newly reported protein, plays critical roles in many biological processes, such as cell cycle, inflammation and tumorigenesis, however, its expression in ovarian serious carcinoma is still poorly understood. In this study, we performed an immunohistochemical study on 101 cases of ovarian serous carcinoma tissues to investigate whether CUEDC2 is a useful biomarker to evaluate the progression of ovarian serous carcinomas. The data showed that the overexpression of CUEDC2 was observed in 59.4% of ovarian serous carcinoma tissue samples and correlated with histopathological grade, patient age at diagnosis, FIGO stage and recurrence. To assess the clinical relevance of CUEDC2, we analyzed the survival follow-up information, the results showed that CUEDC2-positive expression was associated with a shorter disease-free survival time, the median disease-free survival time of CUEDC2-positive patients was 36.0 months compared with 53.9 months of CUEDC2-negative ones (Log-rank χ²=6.149, P=0.013). Collectively, our results suggested that CUEDC2 may be a promising biomarker to evaluate the progression of serous ovarian carcinoma and to predict likely relapse of ovarian serous carcinoma.

Keywords: ovarian serous carcinoma, CUEDC2, recurrence, prognosis

Citation styles

APA

Wang, A., Guo, C., Sun, Y., Lu, L., Wang, Y., Wang, Q., Zhang, Y., Zhang, H., Wang, L., Gu, Y., Liu, A. (2015). Overexpression of CUEDC2 Predicts Poor Prognosis in Ovarian Serous Carcinomas. Journal of Cancer, 6(6), 542-547. https://doi.org/10.7150/jca.11420.

ACS

Wang, A.; Guo, C.; Sun, Y.; Lu, L.; Wang, Y.; Wang, Q.; Zhang, Y.; Zhang, H.; Wang, L.; Gu, Y.; Liu, A. Overexpression of CUEDC2 Predicts Poor Prognosis in Ovarian Serous Carcinomas. J. Cancer 2015, 6 (6), 542-547. DOI: 10.7150/jca.11420.

NLM

CSE

Wang A, Guo C, Sun Y, Lu L, Wang Y, Wang Q, Zhang Y, Zhang H, Wang L, Gu Y, Liu A. 2015. Overexpression of CUEDC2 Predicts Poor Prognosis in Ovarian Serous Carcinomas. J Cancer. 6(6):542-547.

This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) License. See http://ivyspring.com/terms for full terms and conditions.